Adverum Biotechnologies, Inc. 4
4 · Adverum Biotechnologies, Inc. · Filed May 13, 2016
Insider Transaction Report
Form 4
Cleveland Paul B
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2016-05-11+381,000→ 381,000 totalExercise: $4.14Exp: 2026-05-10→ Common Stock (381,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest and become exercisable on the first anniversary of May 11, 2016 (the "Vesting Commencement Date"), and then 1/48th of the shares subject to the option vest and become exercisable monthly thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.